Invention Grant
- Patent Title: Anti-ErbB2 antibody variants
- Patent Title (中): 抗ErbB2抗体变体
-
Application No.: US14399265Application Date: 2013-04-26
-
Publication No.: US09403912B2Publication Date: 2016-08-02
- Inventor: Seung-Kee Moon , So-Ra Park , Ki-Young An
- Applicant: CHONG KUN DANG PHARMACEUTICAL CORP.
- Applicant Address: KR Seoul
- Assignee: CHONG KUN DANG PHARMACEUTICAL CORP.
- Current Assignee: CHONG KUN DANG PHARMACEUTICAL CORP.
- Current Assignee Address: KR Seoul
- Agency: Clark & Elbing LLP
- Agent Susan M. Michaud
- Priority: KR10-2012-0048805 20120508
- International Application: PCT/KR2013/003635 WO 20130426
- International Announcement: WO2013/168918 WO 20131114
- Main IPC: C07K16/32
- IPC: C07K16/32
Abstract:
The present invention relates to anti-ErbB2 antibody variants or antigen-binding fragments thereof, nucleic acid molecules encoding them, and their uses. The antibody variants of the present invention are capable of binding to ErbB2 with high affinity. Therefore, the antibody variants are ability to effectively prevent or treat various cancers with a low amount.
Public/Granted literature
- US20150104443A1 ANTI-ERBB2 ANTIBODY VARIANTS Public/Granted day:2015-04-16
Information query
